FormVision is a spin-off of the Netherlands Cancer Institute. It was established to commercialize ALEA, which is used to collect data of clinical trials.
Role in CCE_DART
The participation of FormVision BV will bring the commercialization and business development perspective, an IT technology view and vast experience in regulatory compliance of IT systems used in clinical trials. It will provide a focus on the deployment model of deliverables beyond the scope of the CCE_DART project as well as feasibility options based on business cases.